|
|
||||||||
-Galactosylceramide in Mice

*
Pharmaceutical Research Laboratory, Kirin Brewery Company, Takasaki, Japan; and
Division of Basic Traumatology, National Defense Medical College Research Institute, Tokorozawa, Japan
The role of mouse liver NK1.1 Ag+ T (NKT) cells
in the antitumor effect of
-galactosylceramide (
-GalCer) has been
unclear. We now show that, whereas
-GalCer increased the serum
IFN-
concentration and alanine aminotransferase activity in NK
cell-depleted C57BL/6 (B6) mice and B6-beige/beige mice
similarly to its effects in control B6 mice, its enhancement of the
antitumor cytotoxicity of liver mononuclear cells (MNCs) was abrogated.
Depletion of both NK and NKT cells in B6 mice reduced all these effects
of
-GalCer. Injection of Abs to IFN-
also inhibited the
-GalCer-induced increase in antitumor cytotoxicity of MNCs.
-GalCer induced the expression of Fas ligand on NKT cells in the
liver of B6 mice. Whereas
-GalCer did not increase serum alanine
aminotransferase activity in B6-lpr/lpr mice and
B6-gld/gld mice, it increased the antitumor cytotoxicity of
liver MNCs. The
-GalCer-induced increase in survival rate apparent
in B6 mice injected intrasplenically with B16 tumor cells was abrogated
in beige/beige mice, NK cell-depleted B6 mice, and B6 mice
treated with Abs to IFN-
. Depletion of CD8+ T cells did
not affect the
-GalCer-induced antitumor cytotoxicity of liver MNCs
but reduced the effect of
-GalCer on the survival of B6 mice. Thus,
IFN-
produced by
-GalCer-activated NKT cells increases both the
innate antitumor cytotoxicity of NK cells and the adaptive antitumor
response of CD8+ T cells, with consequent inhibition of
tumor metastasis to the liver. Moreover, NKT cells mediate
-GalCer-induced hepatocyte injury through Fas-Fas ligand
signaling.
This article has been cited by other articles:
![]() |
A. Motegi, M. Kinoshita, A. Inatsu, Y. Habu, D. Saitoh, and S. Seki IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice J. Leukoc. Biol., October 1, 2008; 84(4): 1047 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, S. Cho, A. Ueno, L. Cheng, B.-Y. Xu, M. D. Desrosiers, Y. Shi, and Y. Yang Ligand-Dependent Induction of Noninflammatory Dendritic Cells by Anergic Invariant NKT Cells Minimizes Autoimmune Inflammation J. Immunol., August 15, 2008; 181(4): 2438 - 2445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Biburger and G. Tiegs Activation-induced NKT cell hyporesponsiveness protects from {alpha}-galactosylceramide hepatitis and is independent of active transregulatory factors J. Leukoc. Biol., July 1, 2008; 84(1): 264 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Ajuebor Role of NKT Cells in the Digestive System. I. Invariant NKT cells and liver diseases: is there strength in numbers? Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G651 - G656. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Safadi, E. Zigmond, O. Pappo, Z. Shalev, and Y. Ilan Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution Int. Immunol., August 13, 2007; (2007) dxm069v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-c. Chen, R. Wang, X. Zhao, Y.-q. Wei, M. Hu, Y.-s. Wang, X.-w. Zhang, R. Zhang, L. Zhang, B. Yao, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs Carcinogenesis, December 1, 2006; 27(12): 2434 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kinoshita, N. Shinomiya, S. Ono, H. Tsujimoto, T. Kawabata, A. Matsumoto, H. Hiraide, and S. Seki Restoration of Natural IgM Production from Liver B Cells by Exogenous IL-18 Improves the Survival of Burn-Injured Mice Infected with Pseudomonas aeruginosa J. Immunol., October 1, 2006; 177(7): 4627 - 4635. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Nagaraj, C Ziske, J Strehl, D Messmer, T Sauerbruch, and I. Schmidt-Wolf Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo Int. Immunol., August 1, 2006; 18(8): 1279 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Brutkiewicz CD1d Ligands: The Good, the Bad, and the Ugly J. Immunol., July 15, 2006; 177(2): 769 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ragin, N. Sahu, and A. August Differential Regulation of Cytokine Production by CD1d-Restricted NKT Cells in Response to Superantigen Staphylococcal Enterotoxin B Exposure Infect. Immun., January 1, 2006; 74(1): 282 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Margalit, S. A. Ghazala, R. Alper, E. Elinav, A. Klein, V. Doviner, Y. Sherman, B. Thalenfeld, D. Engelhardt, E. Rabbani, et al. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G917 - G925. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kojo, K.-i. Seino, M. Harada, H. Watarai, H. Wakao, T. Uchida, T. Nakayama, and M. Taniguchi Induction of Regulatory Properties in Dendritic Cells by V{alpha}14 NKT Cells J. Immunol., September 15, 2005; 175(6): 3648 - 3655. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Ko, H.-J. Ko, W.-S. Chang, S.-H. Park, M.-N. Kweon, and C.-Y. Kang {alpha}-Galactosylceramide Can Act As a Nasal Vaccine Adjuvant Inducing Protective Immune Responses against Viral Infection and Tumor J. Immunol., September 1, 2005; 175(5): 3309 - 3317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Osada, M. A. Morse, H. K. Lyerly, and T. M. Clay Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs Int. Immunol., September 1, 2005; 17(9): 1143 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Biburger and G. Tiegs {alpha}-Galactosylceramide-Induced Liver Injury in Mice Is Mediated by TNF-{alpha} but Independent of Kupffer Cells J. Immunol., August 1, 2005; 175(3): 1540 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Haraguchi, T. Takahashi, A. Matsumoto, T. Asai, Y. Kanda, M. Kurokawa, S. Ogawa, H. Oda, M. Taniguchi, H. Hirai, et al. Host-Residual Invariant NK T Cells Attenuate Graft-versus-Host Immunity J. Immunol., July 15, 2005; 175(2): 1320 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Bezbradica, A. K. Stanic, N. Matsuki, H. Bour-Jordan, J. A. Bluestone, J. W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce Distinct Roles of Dendritic Cells and B Cells in Va14Ja18 Natural T Cell Activation In Vivo J. Immunol., April 15, 2005; 174(8): 4696 - 4705. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Crough, M. Nieda, and A. J. Nicol Granulocyte Colony-Stimulating Factor Modulates {alpha}-Galactosylceramide-Responsive Human V{alpha}24+V{beta}11+ NKT Cells J. Immunol., October 15, 2004; 173(8): 4960 - 4966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahmad and F. Alvarez Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis J. Leukoc. Biol., October 1, 2004; 76(4): 743 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Setiady, P. Pramoonjago, and K. S. K. Tung Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex J. Immunol., July 15, 2004; 173(2): 1051 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nakagawa, T. Inui, I. Nagafune, Y. Tazunoki, K. Motoki, A. Yamauchi, M. Hirashima, Y. Habu, H. Nakashima, and S. Seki Essential Role of Bystander Cytotoxic CD122+CD8+ T Cells for the Antitumor Immunity Induced in the Liver of Mice by {alpha}-Galactosylceramide J. Immunol., June 1, 2004; 172(11): 6550 - 6557. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poirot, C. Benoist, and D. Mathis Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity PNAS, May 25, 2004; 101(21): 8102 - 8107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maeda, A. Shadeo, A. M. MacFadyen, and F. Takei CD1d-Independent NKT Cells in {beta}2-Microglobulin-Deficient Mice Have Hybrid Phenotype and Function of NK and T Cells J. Immunol., May 15, 2004; 172(10): 6115 - 6122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nieda, M. Okai, A. Tazbirkova, H. Lin, A. Yamaura, K. Ide, R. Abraham, T. Juji, D. J. Macfarlane, and A. J. Nicol Therapeutic activation of V{alpha}24+V{beta}11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity Blood, January 15, 2004; 103(2): 383 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Campos, M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P. W. Askenase Cutaneous Immunization Rapidly Activates Liver Invariant V{alpha}14 NKT Cells Stimulating B-1 B Cells to Initiate T Cell Recruitment for Elicitation of Contact Sensitivity J. Exp. Med., December 15, 2003; 198(12): 1785 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Hermans, J. D. Silk, U. Gileadi, M. Salio, B. Mathew, G. Ritter, R. Schmidt, A. L. Harris, L. Old, and V. Cerundolo NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells J. Immunol., November 15, 2003; 171(10): 5140 - 5147. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Y. Crowe, A. P. Uldrich, K. Kyparissoudis, K. J. L. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M. J. Smyth, and D. I. Godfrey Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells J. Immunol., October 15, 2003; 171(8): 4020 - 4027. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Baxevanis, A. D. Gritzapis, and M. Papamichail In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18 J. Immunol., September 15, 2003; 171(6): 2953 - 2959. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kenna, L. G. Mason, S. A. Porcelli, Y. Koezuka, J. E. Hegarty, C. O'Farrelly, and D. G. Doherty NKT Cells from Normal and Tumor-Bearing Human Livers Are Phenotypically and Functionally Distinct from Murine NKT Cells J. Immunol., August 15, 2003; 171(4): 1775 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayakawa, S. Rovero, G. Forni, and M. J. Smyth {alpha}-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis PNAS, August 5, 2003; 100(16): 9464 - 9469. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuwata, H. Watanabe, S.-Y. Jiang, T. Yamamoto, C. Tomiyama-Miyaji, T. Abo, T. Miyazaki, and M. Naito AIM Inhibits Apoptosis of T Cells and NKT Cells in Corynebacterium-Induced Granuloma Formation in Mice Am. J. Pathol., March 1, 2003; 162(3): 837 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Giaccone, C. J. A. Punt, Y. Ando, R. Ruijter, N. Nishi, M. Peters, B. M. E. von Blomberg, R. J. Scheper, H. J. J. van der Vliet, A. J. M. van den Eertwegh, et al. A Phase I Study of the Natural Killer T-Cell Ligand {alpha}-Galactosylceramide (KRN7000) in Patients with Solid Tumors Clin. Cancer Res., December 1, 2002; 8(12): 3702 - 3709. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inui, R. Nakagawa, S. Ohkura, Y. Habu, Y. Koike, K. Motoki, N. Kuranaga, M. Fukasawa, N. Shinomiya, and S. Seki Age-Associated Augmentation of the Synthetic Ligand- Mediated Function of Mouse NK1.1 Ag+ T Cells: Their Cytokine Production and Hepatotoxicity In Vivo and In Vitro J. Immunol., December 1, 2002; 169(11): 6127 - 6132. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ami, M. Kinoshita, A. Yamauchi, T. Nishikage, Y. Habu, N. Shinomiya, T. Iwai, H. Hiraide, and S. Seki IFN-{gamma} Production from Liver Mononuclear Cells of Mice in Burn Injury As Well As in Postburn Bacterial Infection Models and the Therapeutic Effect of IL-18 J. Immunol., October 15, 2002; 169(8): 4437 - 4442. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Y. Crowe, M. J. Smyth, and D. I. Godfrey A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas J. Exp. Med., July 1, 2002; 196(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Trobonjaca, A. Kroger, D. Stober, F. Leithauser, P. Moller, H. Hauser, R. Schirmbeck, and J. Reimann Activating Immunity in the Liver. II. IFN-{beta} Attenuates NK Cell-Dependent Liver Injury Triggered by Liver NKT Cell Activation J. Immunol., April 15, 2002; 168(8): 3763 - 3770. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |